Literature DB >> 32679601

Single-bite versus double-bite technique for mapping biopsies during endoscopic surveillance for hereditary diffuse gastric cancer: a single-center, randomized trial.

Apostolos Pappas1, Wei Keith Tan1,2,3, William Waldock1, Susan Richardson4, Monika Tripathi5, Wladyslaw Januszewicz1,6, Geoffrey Roberts7, Maria O'Donovan5, Rebecca C Fitzgerald1, Massimiliano di Pietro1.   

Abstract

BACKGROUND : Endoscopic surveillance is recommended in patients with hereditary diffuse gastric cancer (HDGC) who refuse or want to delay surgery. Because early signet-ring cell carcinoma (SRCC) can be inconspicuous, the current surveillance endoscopy protocol entails 30 random biopsies, which are time-consuming. This study aimed to compare single-bite and double-bite techniques in HDGC surveillance. METHODS : Between October 2017 and December 2018, consecutive patients referred for HDGC surveillance were prospectively randomized to the single- or double-bite arm. The primary outcome was the diagnostic yield for SRCC foci. Secondary outcomes were: procedural time for random biopsies; comfort score; biopsy size; and quality of specimens, the latter assessed by the presence of muscularis mucosa, crush artifact, and proportion usable for diagnostic assessment. RESULTS : 25 patients were randomized to the single-bite arm and 23 to the double-bite arm. SRCC foci were detected in three and four patients in the single- and double-bite arms, respectively (P = 0.70). The procedural time for the double-bite arm (12 minutes, interquartile range [IQR] 4) was significantly shorter than for the single-bite arm (15 minute, IQR 6; P = 0.01), but comfort scores were similar. The size of the biopsies in the double-bite arm was significantly smaller than in single-bite arm (2.5 mm vs. 3.0 mm; P < 0.001) but this did not affect the presence of muscularis mucosa (P = 0.73), artifact level (P = 0.11), and diagnostic utility (P = 0.051). CONCLUSION : For patients undergoing HDGC surveillance, the double-bite technique is significantly faster than the single-bite technique. The diagnostic yield for SRCC and the biopsy quality were similar across both groups. Thieme. All rights reserved.

Entities:  

Year:  2020        PMID: 32679601      PMCID: PMC7116833          DOI: 10.1055/a-1201-3125

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  15 in total

1.  Diagnostic quality of biopsy specimens: comparison between a conventional biopsy forceps and multibite forceps.

Authors:  A C Fantin; J Neuweiler; J S Binek; W R Suter; C Meyenberger
Journal:  Gastrointest Endosc       Date:  2001-11       Impact factor: 9.427

2.  One bite or two? A prospective trial comparing colonoscopy biopsy technique in patients with chronic ulcerative colitis.

Authors:  Lawrence C Hookey; David J Hurlbut; Andrew G Day; Paul N Manley; William T Depew
Journal:  Can J Gastroenterol       Date:  2007-03       Impact factor: 3.522

3.  Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families.

Authors:  P D Pharoah; P Guilford; C Caldas
Journal:  Gastroenterology       Date:  2001-12       Impact factor: 22.682

4.  Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria.

Authors:  Rachel S van der Post; Jolanda van Dieren; Anna Grelack; Nicoline Hoogerbrugge; Lizet E van der Kolk; Petur Snaebjornsson; Iris Lansdorp-Vogelaar; J Han van Krieken; Tanya M Bisseling; Annemieke Cats
Journal:  Gastrointest Endosc       Date:  2017-04-25       Impact factor: 9.427

5.  Clinical implications of E-cadherin associated hereditary diffuse gastric cancer.

Authors:  R C Fitzgerald; C Caldas
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

6.  An investigation of the factors effecting high-risk individuals' decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC).

Authors:  Nina Hallowell; Shirlene Badger; Sue Richardson; Carlos Caldas; Richard H Hardwick; Rebecca C Fitzgerald; Julia Lawton
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

7.  Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.

Authors:  Rebecca C Fitzgerald; Richard Hardwick; David Huntsman; Fatima Carneiro; Parry Guilford; Vanessa Blair; Daniel C Chung; Jeff Norton; Krishnadath Ragunath; J Han Van Krieken; Sarah Dwerryhouse; Carlos Caldas
Journal:  J Med Genet       Date:  2010-07       Impact factor: 6.318

Review 8.  Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.

Authors:  Rachel S van der Post; Ingrid P Vogelaar; Fátima Carneiro; Parry Guilford; David Huntsman; Nicoline Hoogerbrugge; Carlos Caldas; Karen E Chelcun Schreiber; Richard H Hardwick; Margreet G E M Ausems; Linda Bardram; Patrick R Benusiglio; Tanya M Bisseling; Vanessa Blair; Eveline Bleiker; Alex Boussioutas; Annemieke Cats; Daniel Coit; Lynn DeGregorio; Joana Figueiredo; James M Ford; Esther Heijkoop; Rosella Hermens; Bostjan Humar; Pardeep Kaurah; Gisella Keller; Jennifer Lai; Marjolijn J L Ligtenberg; Maria O'Donovan; Carla Oliveira; Hugo Pinheiro; Krish Ragunath; Esther Rasenberg; Susan Richardson; Franco Roviello; Hans Schackert; Raquel Seruca; Amy Taylor; Anouk Ter Huurne; Marc Tischkowitz; Sheena Tjon A Joe; Benjamin van Dijck; Nicole C T van Grieken; Richard van Hillegersberg; Johanna W van Sandick; Rianne Vehof; J Han van Krieken; Rebecca C Fitzgerald
Journal:  J Med Genet       Date:  2015-05-15       Impact factor: 6.318

9.  Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status.

Authors:  Emma Z Mi; Ella Z Mi; Massimiliano di Pietro; Maria O'Donovan; Richard H Hardwick; Susan Richardson; Hisham Ziauddeen; Paul C Fletcher; Carlos Caldas; Marc Tischkowitz; Krish Ragunath; Rebecca C Fitzgerald
Journal:  Gastrointest Endosc       Date:  2017-07-06       Impact factor: 9.427

10.  Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance.

Authors:  Yean Cheant Lim; Massimiliano di Pietro; Maria O'Donovan; Susan Richardson; Irene Debiram; Susan Dwerryhouse; Richard H Hardwick; Marc Tischkowitz; Carlos Caldas; Krish Ragunath; Rebecca C Fitzgerald
Journal:  Gastrointest Endosc       Date:  2014-01-25       Impact factor: 9.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.